BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 21605357)

  • 21. Bivariate random-effects meta-analysis of sensitivity and specificity with the Bayesian SAS PROC MCMC: methodology and empirical evaluation in 50 meta-analyses.
    Menke J
    Med Decis Making; 2013 Jul; 33(5):692-701. PubMed ID: 23475941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modelling heterogeneity variances in multiple treatment comparison meta-analysis--are informative priors the better solution?
    Thorlund K; Thabane L; Mills EJ
    BMC Med Res Methodol; 2013 Jan; 13():2. PubMed ID: 23311298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computational issues in fitting joint frailty models for recurrent events with an associated terminal event.
    Toenges G; Jahn-Eimermacher A
    Comput Methods Programs Biomed; 2020 May; 188():105259. PubMed ID: 31862679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modelling and estimating heterogeneous variances in threshold models for ordinal discrete data via Winbugs/Openbugs.
    Foulley JL; Jaffrézic F
    Comput Methods Programs Biomed; 2010 Jan; 97(1):19-27. PubMed ID: 19520453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bayesian Estimation with Informative Priors is Indistinguishable from Data Falsification.
    García-Pérez MÁ
    Span J Psychol; 2019 Oct; 22():E45. PubMed ID: 31640834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient estimation and prediction for the Bayesian binary spatial model with flexible link functions.
    Roy V; Evangelou E; Zhu Z
    Biometrics; 2016 Mar; 72(1):289-98. PubMed ID: 26331903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. parallelMCMCcombine: an R package for bayesian methods for big data and analytics.
    Miroshnikov A; Conlon EM
    PLoS One; 2014; 9(9):e108425. PubMed ID: 25259608
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selection of a statistical analysis method for the Glasgow Outcome Scale-Extended endpoint for estimating the probability of favorable outcome in future severe TBI clinical trials.
    Wang Y; Yeatts SD; Martin RH; Silbergleit R; Rockswold GL; Barsan WG; Korley FK; Rockswold S; Gajewski BJ
    Stat Med; 2023 Nov; 42(25):4582-4601. PubMed ID: 37599009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
    Dohoo I; Stryhn H; Sanchez J
    Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implementing informative priors for heterogeneity in meta-analysis using meta-regression and pseudo data.
    Rhodes KM; Turner RM; White IR; Jackson D; Spiegelhalter DJ; Higgins JP
    Stat Med; 2016 Dec; 35(29):5495-5511. PubMed ID: 27577523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of an ordinal outcome in a multicentric randomized controlled trial: application to a 3- arm anti- malarial drug trial in Cameroon.
    Whegang SY; Basco LK; Gwét H; Thalabard JC
    BMC Med Res Methodol; 2010 Jun; 10():58. PubMed ID: 20565837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bayesian methods of analysis for cluster randomized trials with binary outcome data.
    Turner RM; Omar RZ; Thompson SG
    Stat Med; 2001 Feb; 20(3):453-72. PubMed ID: 11180313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial.
    Zampieri FG; Casey JD; Shankar-Hari M; Harrell FE; Harhay MO
    Am J Respir Crit Care Med; 2021 Mar; 203(5):543-552. PubMed ID: 33270526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria parasite clearance rate regression: an R software package for a Bayesian hierarchical regression model.
    Sharifi-Malvajerdi S; Zhu F; Fogarty CB; Fay MP; Fairhurst RM; Flegg JA; Stepniewska K; Small DS
    Malar J; 2019 Jan; 18(1):4. PubMed ID: 30611278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of globally obtained informative priors on bayesian safety performance functions developed for Australian crash data.
    Afghari AP; Haque MM; Washington S; Smyth T
    Accid Anal Prev; 2019 Aug; 129():55-65. PubMed ID: 31108237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fitting parametric random effects models in very large data sets with application to VHA national data.
    Gebregziabher M; Egede L; Gilbert GE; Hunt K; Nietert PJ; Mauldin P
    BMC Med Res Methodol; 2012 Oct; 12():163. PubMed ID: 23095325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MIXOR: a computer program for mixed-effects ordinal regression analysis.
    Hedeker D; Gibbons RD
    Comput Methods Programs Biomed; 1996 Mar; 49(2):157-76. PubMed ID: 8735023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating relative risks in multicenter studies with a small number of centers - which methods to use? A simulation study.
    Pedroza C; Truong VTT
    Trials; 2017 Nov; 18(1):512. PubMed ID: 29096682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects.
    Pradhan S; Song B; Lee J; Chae JW; Kim KI; Back HM; Han N; Kwon KI; Yun HY
    BMC Med Res Methodol; 2017 Dec; 17(1):154. PubMed ID: 29191177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.